Monday 28 December 2015

Deep Brain Stimulators Market Hits USD 1.6 Billion By 2020: Grand View Research, Inc.



Global deep brain stimulators market is expected to reach USD 1,592.9 million by 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of Parkinson’s disease coupled with rising demand for cost effective & minimally invasive surgical procedures are the factors attributing towards the growth of deep brain stimulators market.  According to statistics published by Parkinson Disease Foundation, approximately 10 million people were suffering from this disease in 2010 and the number was anticipated to grow manifolds over the forecast period thereby contributing to the overall industry growth.
The significant increase in the adoption of DBS by neurologist for the treatment of Parkinson’s disease, essential tremors, obsessive compulsive disorder and Dystonia is expected to drive the market growth in coming years. Pending commercialization approval from the U.S. FDA for use of DBS in treatment of refractory epilepsy is also expected to boost the market growth in near future. Furthermore, introduction of technologically advanced selective current steering and fractionation of electric current is further expected to enhance the usage of deep brain stimulators in the near future.

U.S. deep brain stimulators market, by application, 2012-2020 (USD Million)
U.S. deep brain stimulators market 

Further key findings from the study suggest:
  • DBS found wide application in Parkinson’s disease treatment and is expected to grow at CAGR of above 18.0% due to associated benefits such as fewer side effects, improvised motor symptoms for longer time period and tracking of momentary fluctuations.  In addition, shifting of preference from conventional oral medications to DBS, due to drug resistant nature of Parkinson’s disease is further expected to increase adoption of DBS over the forecast period.
  • Obsessive compulsive disorder followed Parkinson’s disease in terms of revenue share due to failure of conventional serotonin reuptake inhibitors (SSRi) treatment and offered benefits such as adjustable & reversible stimulations, and nondestructive nature of treatment.  
  • North America held the dominant share, accounting for over 50.0% in 2013. Presence of sophisticated healthcare infrastructure, increasing awareness levels of patients and healthcare personnel and supportive reimbursement policies are some of the key reasons driving growth of deep brain stimulators regional industry.
  • Asia Pacific region is expected to be fastest growing market for DBS and grow at CAGR of over 18.0% during the forecast period. Constantly improving healthcare facility, presence of high unmet needs and rising expenditure levels are accounted for its significant growth.
  • Key players of deep brain stimulators industry include Aleva Neurotherapeutics SA, Boston Scientific Corporation, St. Jude Medical, and Medtronic Plc. Increasing clinical applications of DBS systems and extensive R&D pertaining to development of advanced technology are the factors propelling industrial growth. Players are adopting competitive strategy such as new product development for sustaining the competition.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global deep brain stimulators market on the basis of application and region:
Global Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2012 – 2020)
  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Obsessive Compulsive Disorder (OCD)
  • Depression
  • Dystonia
  • Parkinson’s Disease
  • Others
Deep Brain Stimulators Regional Outlook (Revenue, USD Billion, 2012 – 2020)
  • North America
    • U.S.
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • Japan
  • RoW
    • Brazil
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Atrial Fibrillation Market To 2020 – Industry Analysis, Trends: Grand View Research, Inc.



The Global Atrial Fibrillation Market is expected to reach USD 16.17 billion by 2020 growing at a CAGR of 13.2%, according to a new study by Grand View Research, Inc. Growing incidences of atrial fibrillation, strokes and brain damage due to blood clots coupled with a growing global base of geriatric population is expected to be a key driver for this market. Some of the other drivers of this market include the introduction of technological advancements in the fields of radiofrequency and microwave catheter ablation, growing demand for minimally invasive procedures and increasing prevalence of disease causing lifestyle habits such as smoking and excessive alcohol consumption. Pharmacological products for Atrial Fibrillation dominated the overall market in terms of revenue in 2013 at over 55.0%. Relatively low prices associated with these products and the use of anti-coagulants as an add-on therapy to non-pharmacological procedures, are some of the drivers of this segment.
Further key findings from the study suggest:
  • Regionally, North America occupied the largest share of the market, accounting for over 42% of the global revenue in 2013. Its large share is majorly attributed by the presence of high market penetration rates of non-pharmacological procedures and sophisticated reimbursement frameworks.
  • Asia Pacific is expected to register the highest CAGR of 15.3% during the forecast period. Growing demand for non-pharmacological treatments on account of constantly improving healthcare infrastructure, patient awareness and disposable income levels are some of the factors accounting for its rapid growth.
  • Radiofrequency catheter ablation procedures segment is expected to grow at the fastest CAGR of over 15% over the next six years owing to the optimal size of the lesion produced, better maneuverability to make tight bends inside the heart and the time required to produce a lesion. The less invasiveness, smaller incisions and faster recovery times of catheter ablation is expected to drive demand for non-pharmacological treatments.
  • Maze surgery occupied the second largest share of the non-pharmacological treatment market. This can be accounted for by the fact that in most cases it removes the need of life-long anti-coagulants based treatment while reducing occurrence of strokes.
  • Anti coagulants dominated the pharmacological treatment market on account of relatively higher success rates of AF treatment through reducing incidences of blood clot formation and strokes.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Apheresis Equipment Market Analysis, Size, Application Analysis, Regional Outlook, Competitive Strategies, and Forecasts, 2014 To 2020



The Global Apheresis Equipment Market is expected to reach USD 2,885.6 million by 2020, growing at an estimated CAGR of 11.5% from 2014 to 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of blood disorders such as bleeding problem and platelet disorder are expected to drive market growth during the forecast period. In addition, growing prevalence of chronic diseases such as cancer or autoimmune diseases, supply of platelets owing to an increasing number of platelet donors, improvement in healthcare infrastructure and facilities and demand for plasma by biopharmaceutical companies are also expected to serve this market as drivers.
Apheresis machine dominated the overall product market in terms of share in 2013, mainly due to its high price. On the other hand, disposable apheresis kits are expected to grow at the fastest CAGR of 14.0% from 2014 to 2020. Increasing initiatives aimed at curbing incidence rates of infectious diseases such as bloodstream infection or BSI and hospital acquired infections or HAIs are expected to augment their market growth over the next six years. Plasmapheresis dominated the procedures market in 2013, with revenue estimated at over USD 746.8 million, owing to its high applicability in donor apheresis. The demand for photopheresis is anticipated to grow rapidly, at an estimated CAGR of 13.4% from 2014 to 2020, due to increasing prevalence of sezary syndrome, principally in patients with increasing circulating sezary cells level.
Further key findings from the study suggest:

• Neurology dominated the application market in terms of share at over 50.2% in 2013, due to increasing prevalence of blood disorder, plasma exchange due to growing rates of multiple sclerosis majority in the U.S.
• Membrane filtration was the most dominant technology in the apheresis market, with revenue estimated at over USD 805.9 million in 2013. Centrifugation is expected to grow at the highest CAGR of 12.6% from 2014 to 2020. It finds usage in the apheresis of any blood component and is not restricted to plasma exchange as membrane filtration.
• North America was the largest regional market in 2013, accounting for over 48.5% of global revenue due to the presence of high patient awareness levels, healthcare expenditure and sophisticated healthcare infrastructure.
• Asia Pacific expected to grow at the fastest CAGR of 13.5% from 2014 to 2020. Large presence of unmet medical needs coupled with constantly improving healthcare infrastructure in emerging markets of India and China are some of the factors accounting for its rapid growth.
• Key industry participants include Asahi Kasei Kuraray Medical Co., Ltd., Terumo BCT Inc., Haemonetics Corp., Kawasumi Laboratories Inc., Hemacare Corporation, Fenwal Inc. and others.
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
For the purpose of this study, Grand View Research has segmented the apheresis equipment market on the basis of product, application, procedure, technology and region:
Apheresis Equipment Product Outlook
            • Devices
            • Disposables
 Apheresis Equipment Application Outlook
            • Renal diseases
            • Hematology
            • Neurology
            • Others
Apheresis Equipment Procedure Outlook
            • Plasmapheresis
            • LDL-apheresis
            • Plateletpheresis
            • Leukapheresis
            • Photophereis
            • Erythrocytapheresis
            • Others
Apheresis Equipment Technology Outlook
            • Membrane Filtration
            • Centrifugation
Apheresis Equipment Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:

Sunday 27 December 2015

Sleep Apnea Devices Market Share, Application Analysis, Industry Outlook, Forecast Report 2014 To 2020



Global sleep apnea device market is expected to reach USD 6.8 billion by 2020, according to a new study by Grand View Research Inc. Rising prevalence of sleep related conditions coupled with lifestyle associated disorders are expected to serve this market as a high impact rendering driver. In addition, rising prevalence of sleep apnea comorbidities such as hypertension, diabetes, obesity, congestive heart failure, and atrial fibrillation is expected to increase the demand of these equipment over the forecast period. Rising geriatric population base is more prone to development of sleep-related disorders; hence, acts as a high impact rendering driver for this market. Technological advancements such as devices, which do not require mask, machine, and external power source, are expected to increase market demand. Furthermore, large patient pool of this disease is undiagnosed; hence, government is taking initiatives to promote early diagnosis, thereby opening up avenues for the market players.
Further key findings from the study suggest:
  • Diagnostic devices consisting of actigraphy systems, polysomnography (PSG), respiratory polygraph, and single channel screening pulse oximeters held substantial share in the product segment. This can be attributed to rising awareness of early and preventive diagnosis.
  • Actigraphy systems in diagnostics devices are expected to witness lucrative growth over the forecast period owing to its state-of-the-art design and round-the-clock monitoring
  • Therapeutic devices are anticipated to witness substantial growth in the coming six years. Growing awareness about sleep apnea and its complications are expected to boost the usage of these equipment.
  • North America dominated the regional sleep apnea device market with over 36.0% share. Supportive government initiatives to improve healthcare infrastructure coupled with growing disposable income are anticipated to drive this region’s growth. Moreover, favorable policies such ‘Disability Tax Credit for Sleep Apnea in Canada’ helped the growth of sleep apnea equipment market in the region.
  • Asia Pacific is expected to witness lucrative growth over the forecast period. Favorable government support to improve healthcare delivery with economic development in emerging countries such as India and China are expected to increase demand for these devices.
  • Key players operating in this market include Phillips Healthcare, BMC Medical Co.Ltd., Braebon Medical Corporation, Cadwell Laboratories, Carefusion Corp., Compumedics Limited, Curative Medical Inc., Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical Inc., Invacare Corporation, Nihon Kohden, and ResMed. The key trends witnessed in this market include new product launches, technological advancements, and collaborations to gain competitive advantage.
  • For instance, in February 2015, Carefusion entered into a distribution agreement with Breas Medical for their range of respiratory products
Browse All Reports of this category @ http://www.grandviewresearch.com/industry/medical-devices
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States           
Phone:  1-415-349-0058
Toll Free:  1-888-202-9519
Email:  sales@grandviewresearch.com 
Website:  Grand View Research                          
Blog Site: http://www.divog.org/


Posted by at No comments:
Labels: , , ,
Subscribe to: Posts (Atom)